DOI:
https://doi.org/10.20882/adicciones.180Palabras clave:
Resumen
Citas
Asociación Española de Patología Dual. Estudio epidemiológico para determinar la prevalencia, diagnóstico y actitud terapéutica de la patología dual en la Comunidad de Madrid. Madrid; 2008.
Gual A. Dual diagnosis in Spain. Drug Alcohol Rev 2007; 26: 65-71.
Torrens M, Martín-Santos R, Samet S. Importance of clinical diagnoses for comorbidity studies in substance use disorders. Neurotox Res 2006; 10: 253-61.
Torrens M, Serrano D, Astals M, Pérez-Domínguez G, Martín-Santos R. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. Am J Psychiatry 2004; 161: 1231-7.
Ferrando L, Bobes J, Gibert J, Soto M, Soto O. Mini-International Neuropsychiatric Interview. Versión en Español 5.0.0. 2005. Disponible en: https://www.medical-outcomes.com/HTMLFiles/MINI/MINI.htm [consultado el 21/11/09].
Roca M, Martín-Santos R, Sáiz J, Obiols J, Serrano MJ, Torrens M et al. Diagnostic Interview for Genetic Studies (DIGS): inter-rater and test-retest reliability and validity in a Spanish population. Eur Psychiatry 2007; 22: 44-8.
Zimmerman M, Mattia JI. The reliability and validity of a screening Questionnaire for 13 DSM-IV Axis I disorders (the Psychiatric Diagnostic Screening Questionnaire) in psychiatric outpatients. J Clin Psychiatry 1999; 60: 677–83.
Zimmerman M. The Psychiatric Diagnostic Screening Questionnaire manual. Los Angeles (CA): Western Psychological Services; 2002.
Zimmerman M, Mattia JI. A Self-Report Scale to Help Make Psychiatric Diagnoses: The Psychiatric Diagnostic Screening Questionnaire. Arch Gen Psychiatry 2001; 58: 787-94.
Landis J, Koch G. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
Zimmerman M, Mattia JI. The Psychiatric Diagnostic Screening Questionnaire: Development, reliability and validity. Compr Psychiatry 2001; 42: 175-89.
Rush B, Zaslavska N, Veldhuizen S. A Comparison of alternative approaches for screening for substance abuse in two community mental health services. Toronto: Centre for Addiction and Mental Health. Health Systems Research & Consulting Unit; 2005.
Magruder KM, Sonne SC, Brady KT, Quello S, Martin RH. Screening for co-occurring mental disorders in drug treatment populations. J Drug Issues 2005; 35: 593-605.
Castel S, Rush B, Kennedy S, Fulton K, Toneatto T. Screening for mental health problems among patients with substance use disorders: preliminary findings on the validation of a selfassessment instrument. Can J Psychiatry 2007; 52: 22-7.
Zimmerman M, Sheeran T, Chelminski I, Young D, Screening for
psychiatric disorders in outpatients with DSM-IV substance use disorders. J Subst Abuse Treat 2004; 26: 181-8.
Rush AJ, Zimmerman M, Wisniewski SR, Fava M, Hollon SD, Warden D et al. Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features. J Affect Disord 2005; 87: 43–55.
Fava M, Rush AJ, Alpert JE, Carmin CN, Balasubramani GK, Wisniewski SR et al. What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension. Can J Psychiatry 2006; 51: 823-35.
Howland RH, Rush AJ, Wisniewski SR, Trivedi MH, Warden D, Fava M et al. Concurrent anxiety and substance use disorders among outpatients with major depression: Clinical features and effect on treatment outcome. Drug Alcohol Depend 2009; 99:248–60.



